Symbols / OSCR $14.38 -1.81% Oscar Health, Inc.

Healthcare • Healthcare Plans • United States • NYQ
OSCR Chart
About

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Healthcare Plans Market Cap 4.28B
Enterprise Value 865.70M Income -443.15M Sales 11.70B
Book/sh 3.29 Cash/sh 13.42 Dividend Yield —
Payout 0.00% Employees 2305 IPO —
P/E — Forward P/E 10.68 PEG —
P/S 0.37 P/B 4.37 P/C —
EV/EBITDA -2.36 EV/Sales 0.07 Quick Ratio 0.92
Current Ratio 0.95 Debt/Eq 50.86 LT Debt/Eq —
EPS (ttm) -1.69 EPS next Y 1.35 EPS Growth —
Revenue Growth 17.30% Earnings 2026-05-06 ROA -4.44%
ROE -44.35% ROIC — Gross Margin 14.38%
Oper. Margin -11.90% Profit Margin -3.79% Shs Outstand 262.16M
Shs Float 249.53M Short Float 10.99% Short Ratio 3.87
Short Interest — 52W High 23.80 52W Low 10.69
Beta 1.93 Avg Volume 7.96M Volume 3.47M
Target Price $15.40 Recom None Prev Close $14.64
Price $14.38 Change -1.81%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$15.40
Mean price target
2. Current target
$14.54
Latest analyst target
3. DCF / Fair value
$47.93
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$14.54
Low
$10.00
High
$23.00
Mean
$15.40

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-09 up UBS Sell → Neutral $17
2026-01-05 up Barclays Underweight → Equal-Weight $18
2025-12-11 init Stephens & Co. — → Equal-Weight $17
2025-11-26 up Piper Sandler Neutral → Overweight $25
2025-11-13 main Wells Fargo Underweight → Underweight $11
2025-11-10 main Barclays Underweight → Underweight $13
2025-11-07 main UBS Sell → Sell $12
2025-10-14 init Goldman Sachs — → Neutral $17
2025-10-07 main Wells Fargo Underweight → Underweight $14
2025-08-14 main Piper Sandler Neutral → Neutral $13
2025-07-25 down Baird Outperform → Neutral $14
2025-07-23 main Barclays Underweight → Underweight $11
2025-07-15 down UBS Neutral → Sell $11
2025-07-11 down Wells Fargo Equal-Weight → Underweight $10
2025-07-02 init Barclays — → Underweight $17
2025-06-09 main Piper Sandler Overweight → Overweight $18
2025-03-13 down Wells Fargo Overweight → Equal-Weight $16
2024-12-10 init Jefferies — → Underperform $12
2024-11-06 down B of A Securities Neutral → Underperform $14
2024-10-07 init UBS — → Neutral $23
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-06 BERTOLINI MARK T Chief Executive Officer — 1,000,000 $11.92 $11,920,000
2026-04-02 BERTOLINI MARK T Chief Executive Officer — 5,733,334 — —
2026-03-12 BLACKLEY RICHARD SCOTT Chief Financial Officer — 150,000 $0.00 $0
2026-03-02 BERTOLINI MARK T Chief Executive Officer — 1,596,877 $0.00 $0
2026-03-02 BLACKLEY RICHARD SCOTT Chief Financial Officer — 134,847 $0.00 $0
2026-03-02 BLACKLEY RICHARD SCOTT Chief Financial Officer — 19,221 $13.39 $257,369
2026-03-02 MCANANEY ADAM Officer — 67,424 $0.00 $0
2026-03-02 MCANANEY ADAM Officer — 18,710 $13.39 $250,527
2026-03-02 SCHLOSSER MARIO T Chief Technology Officer — 189,141 $0.00 $0
2026-03-02 SCHLOSSER MARIO T Chief Technology Officer — 24,335 $13.39 $325,846
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
11,701.43
+27.50%
9,177.94
+56.54%
5,862.87
+42.11%
4,125.58
Operating Revenue
11,701.43
+27.50%
9,177.94
+56.54%
5,862.87
+42.11%
4,125.58
Selling General And Administration
2,049.87
+16.74%
1,755.94
+23.24%
1,424.76
+0.38%
1,419.37
General And Administrative Expense
2,049.87
+16.74%
1,755.94
+23.24%
1,424.76
+0.38%
1,419.37
Other Gand A
2,049.87
+16.74%
1,755.94
+23.24%
1,424.76
+0.38%
1,419.37
Other Operating Expenses
23.34
+22127.62%
0.10
-98.52%
7.08
+393.25%
-2.42
Total Expenses
12,138.72
+32.74%
9,144.51
+49.17%
6,130.17
+29.45%
4,735.66
Reconciled Depreciation
28.89
-10.12%
32.15
+4.73%
30.69
+100.84%
15.28
EBIT
-419.70
-834.25%
57.16
+123.55%
-242.70
+58.69%
-587.45
Total Unusual Items
—
—
0.00
0.00
Total Unusual Items Excluding Goodwill
—
—
0.00
0.00
Special Income Charges
—
—
0.00
0.00
Other Special Charges
—
—
—
—
Net Income
-443.15
-1842.49%
25.43
+109.39%
-270.73
+55.35%
-606.27
Pretax Income
-437.30
-1408.25%
33.43
+112.51%
-267.30
+56.19%
-610.08
Net Non Operating Interest Income Expense
-17.60
+25.84%
-23.73
+3.53%
-24.60
-8.75%
-22.62
Interest Expense Non Operating
17.60
-25.84%
23.73
-3.53%
24.60
+8.75%
22.62
Net Interest Income
-17.60
+25.84%
-23.73
+3.53%
-24.60
-8.75%
-22.62
Interest Expense
17.60
-25.84%
23.73
-3.53%
24.60
+8.75%
22.62
Interest Income
—
—
—
31.31
Other Income Expense
28.59
+38.96%
20.58
—
3.88
Tax Provision
5.61
-23.26%
7.30
+121.77%
3.29
+729.83%
-0.52
Tax Rate For Calcs
0.00
-3.93%
0.00
+4.10%
0.00
+23233.33%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-442.90
-1795.58%
26.12
+109.65%
-270.59
+55.61%
-609.55
Net Income From Continuing Operation Net Minority Interest
-443.15
-1842.49%
25.43
+109.39%
-270.73
+55.35%
-606.27
Net Income From Continuing And Discontinued Operation
-443.15
-1842.49%
25.43
+109.39%
-270.73
+55.35%
-606.27
Net Income Continuous Operations
-442.90
-1795.58%
26.12
+109.65%
-270.59
+55.61%
-609.55
Minority Interests
-0.25
+64.01%
-0.69
-414.18%
-0.13
-104.09%
3.28
Normalized Income
-443.15
-1842.49%
25.43
+109.39%
-270.73
+55.35%
-606.27
Net Income Common Stockholders
-443.15
-1842.49%
25.43
+109.39%
-270.73
+55.35%
-606.27
Diluted EPS
-1.69
-1790.00%
0.10
+108.20%
-1.22
+57.19%
-2.85
Basic EPS
-1.69
-1790.00%
0.10
+108.20%
-1.22
+57.19%
-2.85
Basic Average Shares
262.39
-1.30%
265.85
+19.94%
221.66
+4.32%
212.47
Diluted Average Shares
262.39
-1.30%
265.85
+19.94%
221.66
+4.32%
212.47
Diluted NI Availto Com Stockholders
-443.15
-1842.49%
25.43
+109.39%
-270.73
+55.35%
-606.27
Depreciation And Amortization In Income Statement
28.89
-10.12%
32.15
+4.73%
30.69
+100.84%
15.28
Loss Adjustment Expense
10,019.02
+36.64%
7,332.59
+57.96%
4,642.02
+41.49%
3,280.80
Net Policyholder Benefits And Claims
10,019.02
+36.64%
7,332.59
+57.96%
4,642.02
+41.49%
3,280.80
Policyholder Benefits Ceded
144.15
-9.41%
159.13
+255.71%
44.74
-96.53%
1,290.35
Policyholder Benefits Gross
10,163.18
+35.66%
7,491.72
+59.85%
4,686.76
+2.53%
4,571.15
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
6,325.41
+30.68%
4,840.50
+34.40%
3,601.48
-20.44%
4,526.60
Cash Cash Equivalents And Short Term Investments
3,990.61
+85.47%
2,151.65
-15.96%
2,560.15
-13.39%
2,955.88
Cash And Cash Equivalents
2,774.15
+81.65%
1,527.19
-18.35%
1,870.32
+20.00%
1,558.60
Other Short Term Investments
1,216.46
+94.80%
624.46
-9.48%
689.83
-50.63%
1,397.29
Receivables
598.46
-10.97%
672.21
+35.97%
494.39
-57.35%
1,159.22
Accounts Receivable
542.39
-10.71%
607.43
+37.28%
442.46
-60.12%
1,109.36
Other Receivables
56.07
-13.45%
64.78
+24.75%
51.92
+4.14%
49.86
Net PPE
88.35
+32.27%
66.79
+7.85%
61.93
+3.41%
59.89
Investments And Advances
1,216.46
+94.80%
624.46
-9.48%
689.83
-50.63%
1,397.29
Total Liabilities Net Minority Interest
5,344.68
+39.76%
3,824.07
+36.80%
2,795.36
-23.08%
3,634.20
Payables And Accrued Expenses
4,046.66
+36.88%
2,956.42
+41.87%
2,083.95
-27.71%
2,882.87
Payables
4,046.66
+36.88%
2,956.42
+41.87%
2,083.95
-27.71%
2,882.87
Accounts Payable
1,458.96
+4.36%
1,398.08
+36.13%
1,027.01
-24.78%
1,365.38
Other Payable
2,587.70
+66.05%
1,558.34
+47.44%
1,056.94
-30.35%
1,517.49
Long Term Debt And Capital Lease Obligation
430.10
+43.58%
299.56
+0.26%
298.78
+0.26%
298.00
Long Term Debt
430.10
+43.58%
299.56
+0.26%
298.78
+0.26%
298.00
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
977.65
-3.55%
1,013.59
+26.07%
803.97
-9.71%
890.38
Common Stock Equity
977.65
-3.55%
1,013.59
+26.07%
803.97
-9.71%
890.38
Capital Stock
0.00
+50.00%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+50.00%
0.00
+0.00%
0.00
+0.00%
0.00
Preferred Stock
—
—
—
0.00
Share Issued
298.00
+18.82%
250.80
+9.19%
229.70
+6.05%
216.61
Ordinary Shares Number
297.69
+18.84%
250.49
+9.20%
229.39
+6.06%
216.29
Treasury Shares Number
0.32
+0.00%
0.32
+0.13%
0.31
+0.00%
0.31
Additional Paid In Capital
4,256.97
+10.01%
3,869.62
+5.09%
3,682.29
+4.94%
3,509.01
Retained Earnings
-3,294.43
-15.54%
-2,851.28
+0.88%
-2,876.72
-10.39%
-2,605.99
Gains Losses Not Affecting Retained Earnings
18.03
+1086.86%
-1.83
-239.57%
1.31
+113.47%
-9.71
Treasury Stock
2.92
+0.00%
2.92
+0.00%
2.92
+0.00%
2.92
Minority Interest
3.09
+8.74%
2.84
+32.05%
2.15
+6.65%
2.02
Other Equity Adjustments
18.03
+1086.86%
-1.83
-239.57%
1.31
+113.47%
-9.71
Total Equity Gross Minority Interest
980.74
-3.51%
1,016.42
+26.09%
806.12
-9.67%
892.40
Total Capitalization
1,407.74
+7.20%
1,313.14
+19.08%
1,102.74
-7.21%
1,188.38
Invested Capital
1,407.74
+7.20%
1,313.14
+19.08%
1,102.74
-7.21%
1,188.38
Total Debt
430.10
+43.58%
299.56
+0.26%
298.78
+0.26%
298.00
Net Tangible Assets
977.65
-3.55%
1,013.59
+26.07%
803.97
-9.71%
890.38
Tangible Book Value
977.65
-3.55%
1,013.59
+26.07%
803.97
-9.71%
890.38
Derivative Product Liabilities
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,094.85
+11.93%
978.19
+459.42%
-272.16
-171.56%
380.35
Cash Flow From Continuing Operating Activities
1,094.85
+11.93%
978.19
+459.42%
-272.16
-171.56%
380.35
Net Income From Continuing Operations
-442.90
-1795.58%
26.12
+109.65%
-270.59
+55.61%
-609.55
Depreciation And Amortization
28.89
-10.12%
32.15
+4.73%
30.69
+100.84%
15.28
Other Non Cash Items
-10.74
-3479.33%
-0.30
-101.05%
28.61
+857.56%
2.99
Stock Based Compensation
87.65
-20.19%
109.82
-31.22%
159.68
+42.16%
112.33
Deferred Tax
2.45
+204.75%
-2.34
-4131.03%
0.06
+135.15%
-0.17
Deferred Income Tax
2.45
+204.75%
-2.34
-4131.03%
0.06
+135.15%
-0.17
Operating Gains Losses
-1.34
-5721.74%
-0.02
-132.86%
0.07
-94.51%
1.27
Gain Loss On Investment Securities
-1.34
-5721.74%
-0.02
-132.86%
0.07
-94.51%
1.27
Change In Working Capital
1,459.00
+73.93%
838.86
+536.71%
-192.09
-122.47%
855.00
Change In Receivables
98.57
+155.53%
-177.52
-127.90%
636.23
+215.44%
-551.15
Changes In Account Receivables
89.86
+154.57%
-164.67
-125.80%
638.29
+217.78%
-541.95
Change In Payables And Accrued Expense
1,197.08
+88.67%
634.49
+174.09%
-856.36
-185.35%
1,003.32
Change In Payable
1,197.08
+88.67%
634.49
+174.09%
-856.36
-185.35%
1,003.32
Change In Account Payable
167.72
+26.02%
133.09
+133.63%
-395.81
-241.24%
280.23
Change In Other Current Assets
-27.12
-134.83%
-11.55
-202.12%
11.31
+4753.09%
-0.24
Investing Cash Flow
-241.06
+82.63%
-1,387.43
-340.38%
577.19
+354.81%
-226.52
Cash Flow From Continuing Investing Activities
-241.06
+82.63%
-1,387.43
-340.38%
577.19
+354.81%
-226.52
Net PPE Purchase And Sale
-36.37
-30.38%
-27.90
-9.07%
-25.58
+11.84%
-29.01
Purchase Of PPE
-36.37
-30.38%
-27.90
-9.07%
-25.58
+11.84%
-29.01
Capital Expenditure
-36.37
-30.38%
-27.90
-9.07%
-25.58
+11.84%
-29.01
Net Investment Purchase And Sale
-208.96
+84.67%
-1,363.47
-325.35%
605.04
+404.62%
-198.62
Purchase Of Investment
-1,013.92
+52.48%
-2,133.51
-154.91%
-836.98
+29.82%
-1,192.71
Sale Of Investment
804.96
+4.53%
770.04
-46.60%
1,442.02
+45.06%
994.08
Net Other Investing Changes
4.28
+8.81%
3.93
+272.55%
-2.28
-304.03%
1.12
Financing Cash Flow
399.21
+483.74%
68.39
+960.94%
6.45
-97.86%
301.11
Cash Flow From Continuing Financing Activities
399.21
+483.74%
68.39
+960.94%
6.45
-97.86%
301.11
Net Issuance Payments Of Debt
410.00
0.00
0.00
-100.00%
305.00
Issuance Of Debt
410.00
0.00
0.00
-100.00%
305.00
Repayment Of Debt
—
—
0.00
0.00
Long Term Debt Issuance
410.00
0.00
0.00
-100.00%
305.00
Long Term Debt Payments
—
—
0.00
0.00
Net Long Term Debt Issuance
410.00
—
—
305.00
Net Common Stock Issuance
—
—
0.00
0.00
Common Stock Payments
—
—
—
—
Repurchase Of Capital Stock
—
—
—
—
Proceeds From Stock Option Exercised
55.03
-19.53%
68.39
+1628.72%
3.96
+204.54%
1.30
Net Other Financing Charges
-65.82
—
2.49
+147.99%
-5.19
Changes In Cash
1,253.01
+467.61%
-340.85
-209.43%
311.47
-31.54%
454.94
Beginning Cash Position
1,551.12
-18.02%
1,891.97
+19.71%
1,580.50
+40.42%
1,125.56
End Cash Position
2,804.12
+80.78%
1,551.12
-18.02%
1,891.97
+19.71%
1,580.50
Free Cash Flow
1,058.48
+11.38%
950.30
+419.17%
-297.74
-184.74%
351.34
Interest Paid Supplemental Data
12.78
-62.06%
33.69
+45.50%
23.16
+129.75%
10.08
Income Tax Paid Supplemental Data
17.52
+2498.81%
0.67
-72.08%
2.41
+27.52%
1.89
Amortization Of Securities
-29.79
-10.85%
-26.88
+8.50%
-29.37
-1284.44%
2.48
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category